维普期刊资源整合服务平台（V6.5）

385篇 您的检索式：作者名="Hanefeld M"

选中清除导出查看参考文献查看引证文献引用追踪共20页首页上一页第1页下一页末页 /20 跳转

	题名	作者	年代	出处	被引量
1	Postprandial hyperglycaemia and cardiovascular complications of diabetes:an update显示文摘	Davidson J Hanefeld M	2006	Nutr Metab Cardiovasc Dis2006，16，：	1
2	Efficacy and safety ofthe dipeptidyl peptidase-4 inhibitor sitagliptin asmonotherapy in patients with type 2 diabetes mellitus 显示文摘	RAZ I HANEFELD M XU L	2006	Diabetologia2006，49，11：	1
3	Treatment of impaired glucose tolerance with acarbose and its effect on intima-media thickness:a substudy of the STOP-NIDDM trial (study to prevent non-insulin-dependent diabetes mellitus)显示文摘	Hanefeld M	2006	Endocr Pract2006，12，1：	1
4	Postprandial hypergly- caemia and cardiovascular complications of diabetes: an update 显示文摘	Ceriello A Davidson J Hanefeld M	2006	Nutr Metab Cardiovasc Dis2006，16，7：	1
5	Treatment of impaired glucose tolerance with acar-bose and its effect on intima-media thickness:a substudy of theSTOP-NIDDM trial(study to prevent non-insulin-dependentdiabetes mellitus)显示文摘	HANEFELD M	2006	Endocr Pract2006，12，1：	1
6	Diabetes intervention study:multi-intervention trialin newly diagnosed NIDDM显示文摘	Hanefeld M Fischer S Schmechel H a al	1991	Diabetes Care1991，14，：	1
7	Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia显示文摘	Hanefeld M Bounter KP Dikision S	2000	Diabetes Care2000，23，2：	1
8	Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus显示文摘	Raz I Hanefeld M Xu L	2006	Diabetologia2006，49，11：	1
9	Risk factors for myocardial infarction and death in newly detected NIDDM:the diabetes intervention study,11-years follow-up显示文摘	Hanefeld M Fisher S Julius U	1996	Diabetologia1996，39，：	1
10	Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes:the Diabetes in Germany (DIG) study显示文摘	HANEFELD M KOEHLER C GALLO S		0，，06：	1
11	Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in impaired glucose tolerance for atherosclerosis and diabetes study显示文摘	Hanefeld M Koehler C Fuecker K	2003	Diabetes Care2003，26，3：	1
12	Anti-inflammatory effects of plo-glitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the P1OSTAT Study 显示文摘	Hanefeld M Marx N Pfutzner A	2007	J Am Coll Cardiol2007，49，3：	1
13	Dapagliflozin,an SGLT2 inhibitor,for diabetes显示文摘	Hanefeld M Forst T	2010	Lancet2010，375，9733：	1
14	Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia显示文摘	Hanefeld M Bouter KP Dickinson S	2000	Diabetes Care2000，23，2：	1
15	Effect of the angiotensin II receptor antagonist valsartan on lipid profile and glucose metabolism in patients with hypertension显示文摘	Hanefeld M Abletshauser C	2001	J Int Med Res2001，29，4：	1
16	Effect of acarboseon vascular disease in patients with abnormal glucose tolerance显示文摘	HANEFELD M SCHAPER F KOEHLER C	2008	Cardiovasc Drugs Ther2008，22，3：	1
17	Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance显示文摘	Hanefeld M Chiasson JL Koehler C	2004	Stroke2004，35，：	1
18	Conversion of IGT to type 2 diabetes mellitus is associated with incident cases of hypertension: a post-hoc analysis of the STOP-NIDDM trial 显示文摘	Hanefeld M Pistrosch F Koehler C	2012	J Hypertens2012，30，7：	1
19	Im- paired fasting glucose is not a risk factor for athcrosclerosis显示文摘	Hanefeld M Temclkova-Kurktsehiev T Schaper F	1999	Diabet Med1999，16，3：	1
20	Effects of pi- nglitazone versus simvastatin on biomarkers of inflammation in patients on high cardiovascular risk显示文摘	HANEFELD M SCHAPER F APPELT D	2011	Horm Metab Res2011，43，13：	1

返回顶部每页显示：

共20页首页上一页第1页下一页末页 /20 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示